Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Kodiak Sciences Inc. Transaction History

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.

$721 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2024	SELL	$7.09 - $89.45 $1.44 Million - $18.1 Million	-202,803 Closed	0 $0
Q4 2021 May 17, 2024	BUY	$80.85 - $128.49 $76,160 - $121,037	942 Added 0.47%	202,803 $17.2 Billion
Q3 2021 May 17, 2024	BUY	$81.97 - $106.94 $145,086 - $189,283	1,770 Added 0.88%	201,861 $19.4 Billion
Q2 2021 May 17, 2024	BUY	$77.2 - $126.54 $201,414 - $330,142	2,609 Added 1.32%	200,091 $18.6 Billion
Q1 2021 May 17, 2024	BUY	$110.45 - $164.47 $308,928 - $460,022	2,797 Added 1.44%	197,482 $22.4 Billion
Q4 2020 May 17, 2024	BUY	$60.78 - $154.03 $101,563 - $257,384	1,671 Added 0.87%	194,685 $28.6 Billion
Q3 2020 May 17, 2024	BUY	$45.05 - $59.27 $73,386 - $96,550	1,629 Added 0.85%	193,014 $11.4 Billion
Q2 2020 May 17, 2024	BUY	$42.74 - $66.25 $8.18 Million - $12.7 Million	191,385 New	191,385 $10.4 Billion

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$132 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$29.4 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$14.9 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$12.9 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$7.77 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $398M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.

Account